Cardiovascular Disease Prevention: Clinical Trials

16 trials for Cardiovascular Disease Prevention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 recruiting, 4 completed, 1 enrolling by invitation, 1 not yet recruiting. 10 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable10Recruiting 4, Completed 3, Enrolling by invitation 1, Not yet recruiting 1, Unknown 1
Phase 21Recruiting 1

Follow Cardiovascular Disease Prevention: new trials by email Literature Review of Cardiovascular Disease Prevention trials Research Report on Cardiovascular Disease Prevention

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
INTEGRATE-RX: Integrating Clinical Pharmacists in HIV Care to Mitigate Last-Mile Challenges and Reduce Cardiovascular Disease Burden
INTEGRATE-RX - HIV, Hypertension
Not applicableNot yet recruitingTemple University4502026-10-012026-07-17
Longevity Metrics AI/ML Development Study
AIML scored health screening battery - Aging, Mortality
RecruitingLongevity Metrics, Inc.10000002026-08-082026-09-09
Breast Artery Calcification (BAC) and Female Cardiovascular Disease
Cardiac CT Scan, Bloodwork - Cardiovascular Health Risk Communication, Cardiovascular (CV) Risk
RecruitingNorthwell Health2002026-07-312026-09-09
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Semaglutide (Rybelsus®), Placebo - HIV, Alcohol
Phase 2RecruitingVanderbilt University Medical Center2002026-04-172026-05-26
New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases
Interactive digital modules, Antihypertensive Medication Management - Microalbuminuria, Microalbuminuria /Creatinine Ratios ACR
Not applicableRecruitingNew Taipei City Medical Association41622026-02-052026-05-14
Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.
Cardiovascular Diseases (CVD), Cardiovascular Disease Prevention
RecruitingUniversity College Dublin1002025-12-092026-02-10
Akershus Cardiac Examination (ACE) 5 Study
Lung Cancer Screening Plus Program, Standard of Care - Heavy Smokers, Lung Cancer Screening
Not applicableRecruitingUniversity Hospital, Akershus10002025-10-012025-12-24
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
Feminizing GAHT, Masculinizing GAHT - Gender Incongruence, Cardiovascular (CV) Risk
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna5002025-07-182025-09-23
Preventative Screening and Health Coaching in a Food Insecure Population
Longitudinal, Individualized Health Coaching - Cardiovascular Disease Prevention, Cardiometabolic Diseases
Not applicableRecruitingRush University Medical Center2002025-03-012026-08-24
Monitoring and Guidance of Physical Activity During the Maintenance Phase of Cardiac Rehabilitation: the Antwerp Activity Index
Activity score - Cardiac Rehabilitation, Cardiovascular Disease Prevention
Not applicableRecruitingUniversity Hospital, Antwerp3182025-02-172026-05-06
Effects of a Smartphone-Supported Daily Walking Intervention on Psychological Well-Being and Body Composition in Adults With Cardiometabolic Disease
Smartphone-Supported Daily Walking - Cardiovascular Disease Prevention
Not applicableCompletedKlaipėda University4192024-03-182026-06-29
Community Pharmacist Intervention to Enhance Adherence in Cardiovascular Drug Initiators
community pharmacist intervention - Cardiovascular Diseases, Cardiovascular Disease Prevention
Not applicableUnknownUniversity Ghent16002023-10-032023-11-22
Family Matters Intervention
In-home Visits and Food Preparation Activities, Ecological Momentary Intervention, Feedback on Video-recorded Family Meals - Childhood Obesity, Cardiovascular Disease Prevention
Not applicableEnrolling by invitationUniversity of Colorado, Denver5002022-02-112025-09-22
Real-World Evaluation of a Digitally Enabled Cardiac Rehabilitation Program
Digitally enabled cardiac rehabilitation, F2F-CR, Usual Care Group - Heart Disease, Chronic Disease
CompletedBaker Heart and Diabetes Institute1722019-11-302025-02-07
Digital Prevention Program With Telephonic Coaching
Digital Health Platform, Telephonic Coaching - Cardiovascular Risk, Cardiovascular Disease Prevention
Not applicableCompletedVivoptim Solutions26882018-07-132026-02-11
Impact of a Nutritional Supplement on Metabolic Health
Nutrition bar - Cardiovascular Disease Prevention
Not applicableCompletedUCSF Benioff Children's Hospital Oakland162016-04-052017-04-18

Narrower conditions

Cardiovascular Diseases (5)  ·  Hypertension (3)  ·  Motor Activity (3)  ·  Diabetes Mellitus (2)  ·  Hyperlipidemias (2)  ·  Medication Adherence (2)  ·  Anxiety Disorders (1)  ·  Atherosclerosis (1)  ·  Chronic Disease (1)  ·  Cigarette Smoking (1)  ·  Cognitive Dysfunction (1)  ·  Coronary Artery Disease (1)  ·  Dyslipidemias (1)  ·  Frailty (1)  ·  Gender Dysphoria (1)

Broader conditions

Behavior (6)  ·  Cardiovascular Diseases (5)  ·  Vascular Diseases (5)  ·  Nutritional and Metabolic Diseases (4)  ·  Glucose Metabolism Disorders (3)  ·  Mental Disorders (3)  ·  Metabolic Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Arterial Occlusive Diseases (2)  ·  Arteriosclerosis (2)  ·  Endocrine System Diseases (2)  ·  Health Behavior (2)  ·  Lipid Metabolism Disorders (2)  ·  Pathologic Processes (2)  ·  Patient Acceptance of Health Care (2)

Interventions

Maintenance (1)  ·  Standard of Care (1)  ·  semaglutide (1)

Sponsors

Baker Heart and Diabetes Institute (1)  ·  IRCCS Azienda Ospedaliero-Universitaria di Bologna (1)  ·  Klaipėda University (1)  ·  Longevity Metrics, Inc. (1)  ·  New Taipei City Medical Association (1)  ·  Northwell Health (1)  ·  Rush University Medical Center (1)  ·  Temple University (1)  ·  UCSF Benioff Children's Hospital Oakland (1)  ·  University College Dublin (1)  ·  University Ghent (1)  ·  University Hospital, Akershus (1)  ·  University Hospital, Antwerp (1)  ·  University of Colorado, Denver (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (6)  ·  Belgium (2)  ·  Australia (1)  ·  France (1)  ·  Ireland (1)  ·  Italy (1)  ·  Kenya (1)  ·  Lithuania (1)  ·  Norway (1)  ·  Taiwan (1)

Top investigators

Albertas Skurvydas, dr (1)  ·  Ashutosh Lal, MD (1)  ·  Benson Njuguna, MPharm, MPH, MPP (1)  ·  Bruce Ames (1)  ·  Dan Tran, PharmD (1)  ·  Daniel Luger, MD (1)  ·  Hein Heidbuchel (1)  ·  Hilary A Tindle, MD, MPH (1)  ·  Joyce McCann, PhD (1)  ·  Melinda J Carrington (1)  ·  Michele Mietus-Snyder, MD (1)  ·  Nisha Parikh, MD, MPH (1)  ·  Rory Lambe (1)  ·  William E Brandenburg, MD (1)

Results publications

PMID 33079935, PMID 36993265

NIH funding

P60AA032176 (1), R01HL179904 (1), R33HL151978 (1)